• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

双歧杆菌,预测酒精性肝病肝损伤严重程度的优势菌。

, the Predominant Bacterium to Predict the Severity of Liver Injury in Alcoholic Liver Disease.

机构信息

Geriatrics Digestion Department of Internal Medicine, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.

Guangxi Key Laboratory of AIDS Prevention and Treatment, School of Public Health, Guangxi Medical University, Nanning, China.

出版信息

Front Cell Infect Microbiol. 2021 Mar 17;11:649060. doi: 10.3389/fcimb.2021.649060. eCollection 2021.

DOI:10.3389/fcimb.2021.649060
PMID:33816353
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8010180/
Abstract

BACKGROUND

New evidence implies that the imbalance of gut microbiota is associated with the progression of alcoholic liver disease (ALD) and that the composition of gut microbiota is altered in ALD patients. However, the predominant bacterium in patients involved in the progress of ALD has not been identified. The purpose of this study is to investigate the predominant bacterium in the early and end-stages of ALD as well as the relationship between the bacterium and the degree of liver injury.

METHODS

We enrolled 21 alcoholic fatty liver (AFL) patients, 17 alcoholic liver cirrhosis (ALC) patients and 27 healthy controls, and sequenced the 16S rRNA gene of their fecal microbiota. The gut microbiota composition and its relationship with the indicators of clinical hepatic function were assessed using canonical correspondence analysis (CCA), spearman correlation heatmap and multivariate association with linear (MaAsLin) Models.

RESULTS

The composition and structure of gut microbiota changed greatly in different stages of ALD, and the degree of disorder was aggravated with the progression of ALD, even in the early stage. Moreover, the relative abundance of was highly enriched only in patients with ALC (P <0.001), and positively correlated with AST level (P = 0.029). The abundance of distinguished the liver injury of ALC patients from the controls with an area under the receiver-operating characteristic curve (AUC) of 0.877 (P < 0.001).

CONCLUSIONS

These findings indicate that the imbalance of gut microbiota exists at the early and end-stages of ALD, and the degree of disorder is aggravated with the progression of ALD. , as the predominant bacterium, may be a microbiological marker to evaluate the severity of liver injury in ALD patients.

摘要

背景

新的证据表明,肠道微生物群落失衡与酒精性肝病(ALD)的进展有关,并且 ALD 患者的肠道微生物群落组成发生了改变。然而,参与 ALD 进展的患者中的主要细菌尚未确定。本研究旨在研究 ALD 早期和晚期的主要细菌以及该细菌与肝损伤程度之间的关系。

方法

我们纳入了 21 例酒精性脂肪肝(AFL)患者、17 例酒精性肝硬化(ALC)患者和 27 例健康对照者,并对其粪便微生物群的 16S rRNA 基因进行了测序。采用典范对应分析(CCA)、Spearman 相关热图和多元线性关联(MaAsLin)模型评估肠道微生物群落组成及其与临床肝功能指标的关系。

结果

不同阶段的 ALD 中肠道微生物群落的组成和结构发生了很大变化,并且随着 ALD 的进展,紊乱程度加剧,甚至在早期阶段也是如此。此外, 仅在 ALC 患者中高度富集(P<0.001),并且与 AST 水平呈正相关(P=0.029)。 的丰度可将 ALC 患者的肝损伤与对照组区分开来,其受试者工作特征曲线下面积(AUC)为 0.877(P<0.001)。

结论

这些发现表明,肠道微生物群落失衡存在于 ALD 的早期和晚期阶段,并且随着 ALD 的进展,紊乱程度加剧。 作为主要细菌,可能是评估 ALD 患者肝损伤严重程度的微生物学标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49cf/8010180/eec84aedba25/fcimb-11-649060-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49cf/8010180/19a9bf63f27d/fcimb-11-649060-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49cf/8010180/a7f34ac3d143/fcimb-11-649060-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49cf/8010180/71272ce1643b/fcimb-11-649060-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49cf/8010180/bfdba58705c2/fcimb-11-649060-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49cf/8010180/eec84aedba25/fcimb-11-649060-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49cf/8010180/19a9bf63f27d/fcimb-11-649060-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49cf/8010180/a7f34ac3d143/fcimb-11-649060-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49cf/8010180/71272ce1643b/fcimb-11-649060-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49cf/8010180/bfdba58705c2/fcimb-11-649060-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49cf/8010180/eec84aedba25/fcimb-11-649060-g005.jpg

相似文献

1
, the Predominant Bacterium to Predict the Severity of Liver Injury in Alcoholic Liver Disease.双歧杆菌,预测酒精性肝病肝损伤严重程度的优势菌。
Front Cell Infect Microbiol. 2021 Mar 17;11:649060. doi: 10.3389/fcimb.2021.649060. eCollection 2021.
2
Gut microbiota-based machine-learning signature for the diagnosis of alcohol-associated and metabolic dysfunction-associated steatotic liver disease.基于肠道微生物组的机器学习特征用于诊断酒精相关和代谢功能障碍相关脂肪性肝病。
Sci Rep. 2024 Jul 12;14(1):16122. doi: 10.1038/s41598-024-60768-2.
3
Intestinal permeability, microbial translocation, changes in duodenal and fecal microbiota, and their associations with alcoholic liver disease progression in humans.肠通透性、微生物易位、十二指肠和粪便微生物群的变化及其与人类酒精性肝病进展的关系。
Gut Microbes. 2020 Nov 9;12(1):1782157. doi: 10.1080/19490976.2020.1782157. Epub 2020 Jun 26.
4
Bifidobacterium longum subsp. longum BL21 ameliorates alcoholic liver disease in mice through enhancement of the hepatic antioxidant capacity and modulation of the gut microbiota.长双歧杆菌亚种 longum BL21 通过增强肝脏抗氧化能力和调节肠道微生物群来改善小鼠的酒精性肝病。
J Appl Microbiol. 2023 Nov 1;134(11). doi: 10.1093/jambio/lxad251.
5
Characteristics of microbiome-derived metabolomics according to the progression of alcoholic liver disease.根据酒精性肝病的进展情况分析微生物组衍生代谢组学的特征。
Hepatol Int. 2024 Apr;18(2):486-499. doi: 10.1007/s12072-023-10518-9. Epub 2023 Mar 31.
6
New strain of alleviates ethanol-induced liver injury by modulating the gut microbiota and short-chain fatty acid metabolism.新型菌株通过调节肠道微生物群和短链脂肪酸代谢来缓解乙醇引起的肝损伤。
World J Gastroenterol. 2020 Oct 28;26(40):6224-6240. doi: 10.3748/wjg.v26.i40.6224.
7
Sea buckthorn (Hippophae rhamnoides L.) fermentation liquid protects against alcoholic liver disease linked to regulation of liver metabolome and the abundance of gut microbiota.沙棘发酵液通过调节肝脏代谢组和肠道微生物群落丰度防治酒精性肝病。
J Sci Food Agric. 2021 May;101(7):2846-2854. doi: 10.1002/jsfa.10915. Epub 2020 Nov 20.
8
Fecal microbiota manipulation prevents dysbiosis and alcohol-induced liver injury in mice.粪便微生物群操作可预防小鼠的菌群失调和酒精性肝损伤。
J Hepatol. 2017 Apr;66(4):806-815. doi: 10.1016/j.jhep.2016.11.008. Epub 2016 Nov 25.
9
Inulin Ameliorates Alcoholic Liver Disease via Suppressing LPS-TLR4-Mψ Axis and Modulating Gut Microbiota in Mice.菊粉通过抑制 LPS-TLR4-Mψ 轴和调节小鼠肠道微生物群来改善酒精性肝病。
Alcohol Clin Exp Res. 2019 Mar;43(3):411-424. doi: 10.1111/acer.13950. Epub 2019 Jan 20.
10
Gut Microbiota and Alcoholic Liver Disease.肠道微生物群与酒精性肝病
Rev Recent Clin Trials. 2016;11(3):213-9. doi: 10.2174/1574887111666160810100538.

引用本文的文献

1
Gut microbiota in liver diseases: initiation, development and therapy.肝脏疾病中的肠道微生物群:起始、发展与治疗
Front Med (Lausanne). 2025 Jun 4;12:1615839. doi: 10.3389/fmed.2025.1615839. eCollection 2025.
2
Intrahepatic Microbial Heterogeneity in Multifocal Hepatocellular Carcinoma and Its Association with Host Genomic and Transcriptomic Alterations.多灶性肝细胞癌肝内微生物异质性及其与宿主基因组和转录组改变的关联
Cancer Discov. 2025 Aug 4;15(8):1630-1648. doi: 10.1158/2159-8290.CD-24-1259.
3
The gut microbiota: an emerging modulator of drug resistance in hepatocellular carcinoma.

本文引用的文献

1
Gut microbial metabolites as multi-kingdom intermediates.肠道微生物代谢物作为多王国中间产物。
Nat Rev Microbiol. 2021 Feb;19(2):77-94. doi: 10.1038/s41579-020-0438-4. Epub 2020 Sep 23.
2
A Universal Gut-Microbiome-Derived Signature Predicts Cirrhosis.一种通用的肠道微生物组衍生特征可预测肝硬化。
Cell Metab. 2020 Nov 3;32(5):878-888.e6. doi: 10.1016/j.cmet.2020.06.005. Epub 2020 Jun 30.
3
Intestinal permeability, microbial translocation, changes in duodenal and fecal microbiota, and their associations with alcoholic liver disease progression in humans.
肠道微生物群:肝细胞癌耐药性的新兴调节因子。
Gut Microbes. 2025 Dec;17(1):2473504. doi: 10.1080/19490976.2025.2473504. Epub 2025 Mar 5.
4
A Systematic Review of Microbiota in Cirrhosis: A Change Towards a More Pathogenic Predisposition.肝硬化中微生物群的系统评价:向更具致病性的易感性转变。
Int J Mol Sci. 2025 Jan 9;26(2):527. doi: 10.3390/ijms26020527.
5
Characterization of liver, adipose, and fecal microbiome in obese patients with MASLD: links with disease severity and metabolic dysfunction parameters.伴有代谢功能障碍相关脂肪性肝病的肥胖患者肝脏、脂肪组织及粪便微生物群的特征:与疾病严重程度及代谢功能障碍参数的关联
Microbiome. 2025 Jan 14;13(1):9. doi: 10.1186/s40168-024-02004-7.
6
Etiology-Dependent Microbiome Differences in Hepatocellular Carcinoma Development.肝细胞癌发生过程中病因依赖的微生物组差异
Int J Mol Sci. 2024 Dec 17;25(24):13510. doi: 10.3390/ijms252413510.
7
Cell-to-cell and organ-to-organ crosstalk in the pathogenesis of alcohol-associated liver disease.酒精性肝病发病机制中的细胞间和器官间串扰。
eGastroenterology. 2024 Oct;2(4). doi: 10.1136/egastro-2024-100104. Epub 2024 Dec 9.
8
Partially hydrolyzed guar gum suppresses binge alcohol-induced liver fat accumulation via gut environment modulation in mice.部分水解瓜尔胶通过调节小鼠肠道环境抑制暴饮酒精诱导的肝脏脂肪堆积。
J Gastroenterol Hepatol. 2024 Dec;39(12):2700-2708. doi: 10.1111/jgh.16737. Epub 2024 Sep 23.
9
Therapeutic Potential of FB091 in Alleviating Alcohol-Induced Liver Disease through Gut-Liver Axis.FB091 通过肠-肝轴缓解酒精性肝病的治疗潜力。
J Microbiol Biotechnol. 2024 Oct 28;34(10):2100-2111. doi: 10.4014/jmb.2407.07051. Epub 2024 Aug 9.
10
The signatures and crosstalk of gut microbiome, mycobiome, and metabolites in decompensated cirrhotic patients.失代偿期肝硬化患者肠道微生物群、真菌微生物群和代谢物的特征及相互作用
Front Microbiol. 2024 Aug 21;15:1443182. doi: 10.3389/fmicb.2024.1443182. eCollection 2024.
肠通透性、微生物易位、十二指肠和粪便微生物群的变化及其与人类酒精性肝病进展的关系。
Gut Microbes. 2020 Nov 9;12(1):1782157. doi: 10.1080/19490976.2020.1782157. Epub 2020 Jun 26.
4
Liver cirrhosis contributes to the disorder of gut microbiota in patients with hepatocellular carcinoma.肝硬化导致肝癌患者肠道微生物群失调。
Cancer Med. 2020 Jun;9(12):4232-4250. doi: 10.1002/cam4.3045. Epub 2020 Apr 12.
5
Gut microbiota compositional and functional fingerprint in patients with alcohol use disorder and alcohol-associated liver disease.酒精使用障碍和酒精相关性肝病患者的肠道微生物群组成及功能特征
Liver Int. 2020 Apr;40(4):878-888. doi: 10.1111/liv.14383. Epub 2020 Feb 3.
6
Microbiome as a therapeutic target in alcohol-related liver disease.肠道菌群作为酒精性肝病的治疗靶点。
J Hepatol. 2019 Feb;70(2):260-272. doi: 10.1016/j.jhep.2018.10.019.
7
Intestinal HIF-1α deletion exacerbates alcoholic liver disease by inducing intestinal dysbiosis and barrier dysfunction.肠道 HIF-1α 缺失通过诱导肠道菌群失调和屏障功能障碍加重酒精性肝病。
J Hepatol. 2018 Oct;69(4):886-895. doi: 10.1016/j.jhep.2018.05.021. Epub 2018 May 25.
8
Gut Microbiota-Derived Tryptophan Metabolites Modulate Inflammatory Response in Hepatocytes and Macrophages.肠道微生物衍生色氨酸代谢物可调节肝细胞和巨噬细胞的炎症反应。
Cell Rep. 2018 Apr 24;23(4):1099-1111. doi: 10.1016/j.celrep.2018.03.109.
9
High-throughput metagenomic analysis of petroleum-contaminated soil microbiome reveals the versatility in xenobiotic aromatics metabolism.石油污染土壤微生物群落的高通量宏基因组分析揭示了外源芳香族化合物代谢的多样性。
J Environ Sci (China). 2017 Jun;56:25-35. doi: 10.1016/j.jes.2016.08.022. Epub 2016 Oct 1.
10
Recovery of ethanol-induced depletion ameliorates alcoholic liver disease.乙醇诱导的耗竭恢复可改善酒精性肝病。
Gut. 2018 May;67(5):891-901. doi: 10.1136/gutjnl-2016-313432. Epub 2017 May 26.